Private Capital Group’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $27K | Buy |
1,896
+31
| +2% | +$441 | 0.02% | 721 |
|
|
2022
Q1 | $27K | Buy |
1,865
+828
| +80% | +$12K | 0.01% | 906 |
|
|
2021
Q4 | $14K | Sell |
1,037
-369
| -26% | -$4.98K | ﹤0.01% | 1187 |
|
|
2021
Q3 | $23K | Sell |
1,406
-1,763
| -56% | -$28.8K | 0.01% | 1014 |
|
|
2021
Q2 | $53K | Sell |
3,169
-370
| -10% | -$6.19K | 0.01% | 651 |
|
|
2021
Q1 | $65K | Sell |
3,539
-1,575
| -31% | -$28.9K | 0.02% | 529 |
|
|
2020
Q4 | $93K | Buy |
5,114
+2,155
| +73% | +$39.2K | 0.02% | 528 |
|
|
2020
Q3 | $53K | Sell |
2,959
-649
| -18% | -$11.6K | 0.01% | 683 |
|
|
2020
Q2 | $65K | Buy |
3,608
+708
| +24% | +$12.8K | 0.01% | 595 |
|
|
2020
Q1 | $44K | Buy |
2,900
+1,062
| +58% | +$16.1K | 0.01% | 705 |
|
|
2019
Q4 | $36K | Sell |
1,838
-64
| -3% | -$1.25K | 0.01% | 878 |
|
|
2019
Q3 | $33K | Buy |
1,902
+1,521
| +399% | +$26.4K | 0.01% | 963 |
|
|
2019
Q2 | $8K | Sell |
381
-1,521
| -80% | -$31.9K | ﹤0.01% | 1484 |
|
|
2019
Q1 | $39K | Buy |
1,902
+1,326
| +230% | +$27.2K | 0.01% | 899 |
|
|
2018
Q4 | $10K | Sell |
576
-131
| -19% | -$2.27K | ﹤0.01% | 1402 |
|
|
2018
Q3 | $15K | Buy |
707
+140
| +25% | +$2.97K | ﹤0.01% | 1283 |
|
|
2018
Q2 | $11K | Buy |
567
+2
| +0.4% | +$39 | ﹤0.01% | 1400 |
|
|
2018
Q1 | $14K | Buy |
+565
| New | +$14K | ﹤0.01% | 1233 |
|